Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
37%
ALSO IN PJP
PJP
32
HOLDINGS
36%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 5.2% | 5.2% |
|
ABBVIE INC | 9.5% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 6.0% | 5.0% | 5.0% |
|
AMGEN INC | 4.2% | 5.1% | 4.2% |
|
MERCK & CO. INC. | 4.2% | 4.8% | 4.2% |
MEDX Overweight Relative to PJP
|
ELI LILLY & CO | 13.9% |
 |
NOVARTIS AG-ADR | 7.1% |
 |
ALKERMES PLC | 5.8% |
 |
ASTRAZENECA PLC | 4.6% |
|
ABBVIE INC | 4.3% |
|
IONIS PHARMACEUTICALS, INC. | 3.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
CRISPR THERAPEUTICS AG | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.3% |
MEDX Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.2% |
|
GILEAD SCIENCES INC | -4.7% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.6% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.4% |
|
LIGAND PHARMACEUTICALS-CL B | -3.3% |
|
OCULAR THERAPEUTIX INC | -3.2% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -3.2% |
|
TARSUS PHARMACEUTICALS, INC. | -2.9% |